DOOR
Latch is seeking an AI Biologist to evaluate AI agent performance across the genetic medicines pipeline, including gene therapy, gene editing, and RNA therapeutics. The role involves designing realistic program case studies, evaluating preclinical data, and stress-testing AI outputs for scientific soundness. This position contributes to building datasets and AI agent tasks for target validation, drug discovery, and clinical development.
Headquarters
London, England, United Kingdom
Company Size
1-10 employees
Founded
2017
DOOR (formerly Latch) is a full-stack smart building platform built for multifamily, student housing, and similar properties. It unifies access control, smart home automation, and building operations into a single operating system called DOOR OS, with hardware including smart locks, intercoms, cameras, and IoT sensors. DOOR helps property owners and managers streamline operations, reduce costs, and deliver a modern resident experience.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for DOOR.
Advisor – RNA Preclinical Pharmacology, Ocular
Eli Lilly and Company
ADME Project Leadership for Genetic Medicines
Eli Lilly and Company
Scientist/Senior Scientist
ASTARPRD
ADME Project Leadership for Genetic Medicines
Eli Lilly and Company
Associate Scientist, Regeneron Genetic Medicines
Regeneron Pharmaceuticals
Scientific Director | tRNA Biotherapeutics
Jobgether